PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629236
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629236
Lipidomics Equipment Market size was valued at US$ 1,256.78 Million in 2024, expanding at a CAGR of 8.5% from 2025 to 2032.
The lipidomics equipment market involves advanced technologies used to analyze lipids and their metabolic roles in various diseases. Lipidomics, an essential part of systems biology, focuses on understanding lipid profiles and their contributions to cellular functions. A surge in research on the role of lipids in diseases such as cardiovascular disorders, diabetes, and neurological diseases has amplified the demand for lipidomics equipment. According to the American Heart Association, nearly half of the U.S. population has some form of cardiovascular disease, increasing the need for lipidomics research. Additionally, advancements in analytical techniques, such as mass spectrometry and chromatography, enable more precise lipid identification and quantification, fueling market expansion. However, the high cost of lipidomics equipment and the complexity of lipid analysis pose significant barriers to widespread adoption, particularly in developing regions. There are substantial opportunities for market growth in emerging economies, where increasing investments in healthcare and scientific research are accelerating the adoption of advanced lipidomics technologies for drug discovery and personalized medicine.
Lipidomics Equipment Market- Market Dynamics
Rising Research on Lipid-Related Diseases Fuels Growth in the Lipidomics Equipment Market
The increasing focus on lipid-related diseases, such as cardiovascular conditions and diabetes, is driving the growth of the lipidomics equipment market. In particular, advancements in mass spectrometry and chromatography techniques are enabling more detailed lipid profiling. For instance, the National Institutes of Health (NIH) has highlighted the importance of lipid biomarkers in disease diagnostics, further accelerating research. According to a study published by the American Heart Association, lipids are critical in understanding atherosclerosis, a leading cause of heart disease, sparking investments in lipidomic technologies. With a growing number of research projects worldwide focusing on lipid signaling pathways, there has been a rise in demand for specialized lipidomics equipment, especially in academic and pharmaceutical research institutions.
Lipidomics Equipment Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.5% over the forecast period (2025-2032)
Based on product type segmentation, Mass Spectrometers were predicted to show maximum market share in the year 2024
Based on Type segmentation, Targeted Type was the leading Type in 2024
Based on Service segmentation, Biomarker Identification was the leading Service in 2024
Based on region, North America was the leading revenue generator in 2024
The Global Lipidomics Equipment Market is segmented based on Product Type, Type, Service, End-User, and Region.
The market is divided into three categories based on product type: Mass Spectrometers, Chromatography Systems, and Sample Preparation Systems. Mass spectrometers hold the highest priority due to their advanced capabilities in lipid analysis, followed by chromatography systems, which are essential for separating complex lipid mixtures. Sample preparation systems, though vital, rank third in market importance.
The market is divided into two categories based on Type: Targeted and Untargeted. Untargeted lipidomics take precedence, as they provide comprehensive insights into lipid profiles without prior knowledge of specific lipid species, followed by targeted lipidomics, which focuses on analyzing predefined lipid classes or individual lipids for specific research.
Lipidomics Equipment Market- Geographical Insights
The Lipidomics Equipment Market is experiencing significant growth across various regions, with North America leading the charge due to its strong healthcare infrastructure and high research funding. The U.S. National Institutes of Health (NIH) has been a major contributor to lipidomics research, funding numerous projects aimed at understanding lipid-related diseases. Europe follows closely, with countries like Germany, the UK, and France investing in lipidomic technologies for clinical research and drug development. The region's emphasis on personalized medicine and biomarker discovery further boosts market demand. In the Asia-Pacific region, particularly in China and Japan, the market is expanding rapidly due to increased awareness of chronic diseases, a growing healthcare sector, and substantial investments in biomedical research. Additionally, emerging markets in Latin America and the Middle East are gradually adopting lipidomics technologies, supported by improving healthcare facilities and government initiatives to promote advanced medical research. This geographical expansion reflects the rising global focus on lipid-related diseases and precision medicine.
The Lipidomics Equipment Market is highly competitive, with numerous global players driving innovation and technological advancements. Leading companies such as Thermo Fisher Scientific, Agilent Technologies, and Waters Corporation dominate the market by offering cutting-edge lipidomic analytical tools, such as mass spectrometers and chromatography systems. These companies focus on expanding their product portfolios and enhancing research capabilities to meet the growing demand for lipidomics in drug discovery and disease research. Other notable players include PerkinElmer, Sciex, and Bio-Rad Laboratories, which are focusing on partnerships and acquisitions to strengthen their market presence. For instance, Thermo Fisher Scientific recently expanded its product range with state-of-the-art lipidomics solutions to cater to the growing need for precision medicine. Companies are also investing in developing user-friendly platforms to facilitate research, enabling better lipid analysis and reducing time-to-results for clinical applications. As lipidomics is an emerging field, new entrants and collaborations between biotech firms and academic institutions are expected to further intensify competition in the market, driving continuous innovation.
In June 2021, Bruker Corporation announced the launch of a new VIP-HESI ion source, enhancing sensitivity in 4D-Lipidomics workflows by up to 16-fold. This innovation, integrated with the timsTOF Pro 2 platform, facilitates improved identification and quantification of lipids and contaminants.